Group One Trading
AYTU icon

Group One Trading’s AYTU BioPharma AYTU Stock Holding History

Group One Trading’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$19 – 7195
2022
Q4 		$19 Buy
+5
New +$19 ﹤0.01% 7111
2021
Q4 		– Sell
-245
Closed -$14K – 8190
2021
Q3 		$14K Sell
245
-260
-51% -$19.5K ﹤0.01% 7337
2021
Q2 		$51K Sell
505
-810
-62% -$95K ﹤0.01% 6558
2021
Q1 		$200K Buy
+1,315
New +$209K ﹤0.01% 5030

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's AYTU Position: Q1 2026 in Review

Group One Trading held its AYTU BioPharma (AYTU) position steady in Q1 2026 at 37 shares worth $101. The position accounts for ﹤0.01% of the portfolio, ranked #7427.

Group One Trading first reported a position in AYTU in Q1 2021 and has held it in 21 quarters since. The position peaked at $102K in Q2 2021. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • Group One Trading held 37 shares of AYTU BioPharma worth $101 as of Q1 2026.
  • Group One Trading left its AYTU BioPharma share count unchanged in Q1 2026.
  • AYTU BioPharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7427 holding.
  • Group One Trading first reported a position in AYTU BioPharma in Q1 2021 and has held it in 21 quarters since.
  • Group One Trading's AYTU BioPharma position peaked at $102K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.